Common Contracts

Celgene International Sarl

June 9th, 2016

• Filed
  June 9th, 2016

CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ for Protocol GED-0301-CD-004 pre Protokol GED-0301-CD-004 This Clinical Trial Agreement (hereinafter, the “Agreement”) is by and between: Táto zmluva o klinickom skúšaní (ďalej iba „zmlu- va“) sa uzatvára medzi: Celgene Corporation, having its principal office at86 Morris Avenue, Summit, NJ 07901, USA (hereinafter called “Sponsor”) represented for the purposes of this Agreement by Celgene International S.à.r.l, a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux, 2017 Boudry, Switzerland and for the purposes of signing this Agreement by Quintiles Incorporated, a company incorporated under the laws of United States of America, registered with company number 0119582, with registered office address at 4820 Emperor Boulevard, Durham, NC 27703, USA, acting through its affiliates: Quintiles Eastern Holdings GmbH, Stella-Klein-Low-Weg 15 Rund 4, Haus B, OG 4, 1020 Vienna, Austri